This compound is a quinazoline-diamine derivative identified as a related substance impurity of alfuzosin. It is primarily used in pharmaceutical manufacturing and quality control for the characterization and quantification of this impurity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 76362-29-3
N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-N-methylpropane-1,3-diamine Dihydrochloride
pharmaceutical intermediate
Enalaprilat
pharmaceutical raw material
(2S)-1-((2S)-2-(((1R)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid
pharmaceutical raw material
Sultamicillin
pharmaceutical raw material
Lexidronam pentasodium
pharmaceutical raw material
2-N-(3-aminopropyl)-6,7-dimethoxy-2-N-methylquinazoline-2,4-diamine
HVTJQTPDNHTWGI-UHFFFAOYSA-N
CN(CCCN)C1=NC2=CC(=C(C=C2C(=N1)N)OC)OC